(Q35842604)

10 August 2017

1 reference

title

Conditionally replicative adenovirus for gastrointestinal cancers (English)

1 reference

10 August 2017

1 reference

Masato Yamamoto

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

8

1 reference

10 August 2017

page(s)

1241-1250

1 reference

10 August 2017

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Human cancer and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Gene therapy and gastrointestinal cancer: concepts and clinical facts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Gene therapy in gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Molecular aspects of pancreatic cancer and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Gene therapy for pancreatic and biliary malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Treatment of human cancer with mumps virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

A model for tumor suppression using H-1 parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Reovirus as a novel oncolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

RNA viruses as virotherapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Studies on the use of viruses in the treatment of carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Wnt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

The role of COX-2 in intestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Strategies to adapt adenoviral vectors for targeted delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

Experimental models for study of common respiratory viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1241

10.1517/14712598.4.8.1241

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference